Astron Director Increases Indirect Shareholding via Performance Rights Exercise

Astron Limited ( (AU:ATR) ) has issued an update.

Astron Limited has disclosed a change in the indirect shareholding of director Dr Mark Elliott, after his controlled entity Elliott Nominees Pty Ltd exercised a tranche of unquoted performance rights. The transaction, dated 27 March 2026, resulted in the issue of 266,666 new ordinary shares to the nominee entity at no cash consideration, increasing Dr Elliott’s indirect holding to 2,677,818 ordinary shares and reducing his unquoted performance rights balance.

The change reflects the conversion of part of Dr Elliott’s existing performance-based incentives into equity, further aligning his interests with those of shareholders without involving on-market trading or cash transactions. No changes were reported in his interests in contracts, and the company confirmed the dealings did not occur during a closed period requiring prior written clearance, signalling routine compliance with ASX director interest reporting rules.

The most recent analyst rating on (AU:ATR) stock is a Buy with a A$0.90 price target. To see the full list of analyst forecasts on Astron Limited stock, see the AU:ATR Stock Forecast page.

More about Astron Limited

Astron Limited is an Australia-listed company with its shares traded on the ASX. The company operates under Australian corporate and securities regulations, with directors and related entities holding and reporting interests in the firm’s ordinary shares and performance rights in line with market disclosure requirements.

Average Trading Volume: 102,354

Technical Sentiment Signal: Hold

Current Market Cap: A$263.7M

See more insights into ATR stock on TipRanks’ Stock Analysis page.